HRP920383B1 - Mometasone furoate monohydrate, process for making the same and pharmaceutical compositions containing the said compound - Google Patents

Mometasone furoate monohydrate, process for making the same and pharmaceutical compositions containing the said compound

Info

Publication number
HRP920383B1
HRP920383B1 HRP-1497/91A HRP920383A HRP920383B1 HR P920383 B1 HRP920383 B1 HR P920383B1 HR P920383 A HRP920383 A HR P920383A HR P920383 B1 HRP920383 B1 HR P920383B1
Authority
HR
Croatia
Prior art keywords
compound
pharmaceutical compositions
compositions containing
making
mometasone furoate
Prior art date
Application number
HRP-1497/91A
Other languages
English (en)
Inventor
Pui-Ho Yuen
Teresa Etlinger
Charles Eckhart
Nancy Levine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP920383(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of HRP920383A2 publication Critical patent/HRP920383A2/xx
Publication of HRP920383B1 publication Critical patent/HRP920383B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP-1497/91A 1990-09-10 1992-09-21 Mometasone furoate monohydrate, process for making the same and pharmaceutical compositions containing the said compound HRP920383B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10
YU149791A YU48666B (sh) 1990-09-10 1991-09-09 Mometason furoat monohidrat i postupak za njegovo dobijanje

Publications (2)

Publication Number Publication Date
HRP920383A2 HRP920383A2 (en) 1998-06-30
HRP920383B1 true HRP920383B1 (en) 2000-04-30

Family

ID=24320279

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1497/91A HRP920383B1 (en) 1990-09-10 1992-09-21 Mometasone furoate monohydrate, process for making the same and pharmaceutical compositions containing the said compound

Country Status (35)

Country Link
US (1) US6180781B1 (OSRAM)
EP (1) EP0548114B1 (OSRAM)
JP (1) JPH0725789B2 (OSRAM)
KR (1) KR960013445B1 (OSRAM)
CN (1) CN1030920C (OSRAM)
AT (1) ATE113604T1 (OSRAM)
AU (1) AU663471B2 (OSRAM)
BG (1) BG60755B2 (OSRAM)
CA (1) CA2091360C (OSRAM)
CZ (1) CZ281318B6 (OSRAM)
DE (2) DE19875032I2 (OSRAM)
DK (1) DK0548114T5 (OSRAM)
EE (1) EE02962B1 (OSRAM)
ES (1) ES2065701T3 (OSRAM)
FI (1) FI111078B (OSRAM)
HK (1) HK185996A (OSRAM)
HR (1) HRP920383B1 (OSRAM)
HU (1) HU213401B (OSRAM)
IE (1) IE67056B1 (OSRAM)
IL (1) IL99437A (OSRAM)
LU (1) LU90366I2 (OSRAM)
MX (2) MX9203396A (OSRAM)
MY (1) MY106644A (OSRAM)
NL (1) NL980012I2 (OSRAM)
NO (1) NO300548B1 (OSRAM)
NZ (1) NZ239711A (OSRAM)
OA (1) OA09772A (OSRAM)
PH (1) PH30443A (OSRAM)
PL (1) PL165803B1 (OSRAM)
PT (1) PT98905B (OSRAM)
SI (1) SI9111497A (OSRAM)
TW (2) TW272195B (OSRAM)
WO (1) WO1992004365A1 (OSRAM)
YU (1) YU48666B (OSRAM)
ZA (1) ZA917148B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9203396A (es) * 1990-09-10 1992-07-31 Schering Corp Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
US5837699A (en) 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
DE69804998T2 (de) * 1997-10-09 2002-12-12 Schering Corp., Kenilworth Mometasonfuroat-suspensionen zum zerstäuben
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
MXPA01011227A (es) 1999-05-04 2002-07-02 Strakan Ltd Glicosidas androgenas y su actividad androgenica.
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
CA2537185A1 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20090054382A1 (en) * 2005-10-19 2009-02-26 Abhijit Ray Compositions of phosphodiesterase type iv inhibitors
JP2009512676A (ja) 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体アンタゴニストの医薬組成物
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
AU2007298549A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
CN103497185A (zh) * 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
EP2435024B1 (en) 2009-05-29 2016-07-06 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
MX361286B (es) 2013-03-15 2018-12-03 Pearl Therapeutics Inc Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas.
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
MX9203396A (es) * 1990-09-10 1992-07-31 Schering Corp Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.

Also Published As

Publication number Publication date
ATE113604T1 (de) 1994-11-15
HU213401B (en) 1997-06-30
CA2091360A1 (en) 1992-03-11
IL99437A0 (en) 1992-08-18
PT98905A (pt) 1992-09-30
MX9203396A (es) 1992-07-31
BG60755B2 (bg) 1996-02-29
HU9300685D0 (en) 1993-06-28
TW229208B (OSRAM) 1994-09-01
EE02962B1 (et) 1997-02-17
CZ38393A3 (en) 1994-01-19
FI931031L (fi) 1993-03-09
DE69104991T2 (de) 1995-04-20
AU663471B2 (en) 1995-10-12
HUT64361A (en) 1993-12-28
MY106644A (en) 1995-07-31
TW272195B (OSRAM) 1996-03-11
WO1992004365A1 (en) 1992-03-19
YU149791A (sh) 1994-01-20
AU8497491A (en) 1992-03-30
SI9111497A (sl) 1998-04-30
PL165803B1 (pl) 1995-02-28
KR960013445B1 (ko) 1996-10-05
FI931031A0 (fi) 1993-03-09
EP0548114B1 (en) 1994-11-02
DK0548114T5 (da) 1995-01-30
US6180781B1 (en) 2001-01-30
HRP920383A2 (en) 1998-06-30
JPH0725789B2 (ja) 1995-03-22
EP0548114A1 (en) 1993-06-30
DE19875032I2 (de) 2007-04-19
MX9100990A (es) 1992-05-04
HK185996A (en) 1996-10-11
JPH05506667A (ja) 1993-09-30
FI111078B (fi) 2003-05-30
OA09772A (en) 1993-11-30
NZ239711A (en) 1992-09-25
CN1059911A (zh) 1992-04-01
NO930693D0 (no) 1993-02-26
CA2091360C (en) 1997-04-08
NL980012I1 (nl) 1998-05-06
CZ281318B6 (cs) 1996-08-14
NO930693L (no) 1993-02-26
CN1030920C (zh) 1996-02-07
PT98905B (pt) 1998-08-31
ZA917148B (en) 1992-08-26
NL980012I2 (nl) 2004-11-01
IE913155A1 (en) 1992-03-11
DE69104991D1 (de) 1994-12-08
NO300548B1 (no) 1997-06-16
IE67056B1 (en) 1996-02-21
ES2065701T3 (es) 1995-02-16
PH30443A (en) 1997-05-09
LU90366I2 (fr) 1999-05-05
YU48666B (sh) 1999-06-15
IL99437A (en) 1995-05-29

Similar Documents

Publication Publication Date Title
TW229208B (OSRAM)
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
ZA832135B (en) Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
CA2152771A1 (en) 7-o-ethers of taxane derivatives
DE3063905D1 (en) Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
ES477562A1 (es) Procedimiento para preparar derivados de alcanolamina.
ES8504166A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz(b,e) oxepina.
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
ES8800198A1 (es) Procedimiento para preparar derivados de acidos aziridin-2- carboxilicos substituidos en n
IL66192A (en) Albomycin derivatives,their production and pharmaceutical compositions containing them
GR910300116T1 (en) 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
ZA912180B (en) Novel compounds.cephalosporins,process for their preparation and pharmaceutical compositions containing them
JO1711B1 (en) Therapeutic agents
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
GB9018263D0 (en) Tricyclo compounds,processes for their production and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20100907

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20110910